Sharing and reuse of individual participant data from clinical trials: principles and recommendations
暂无分享,去创建一个
Dipak Kalra | Rachel L Knowles | Christian Ohmann | Martin Fenner | Irene Schlünder | Philippe Ravaud | Wolfgang Kuchinke | Christiane Druml | Christian Gluud | Rebecca Kush | Dylan Spalding | Rita Banzi | Karmela Krleža-Jerić | Ari Lukkarinen | Steve Canham | Andrew Newbigging | Mihaela Matei | Catrin Tudur-Smith | Christine Kubiak | Trish Groves | Paul Houston | Luca Clivio | Davina Ghersi | Helmut Sitter | C. Ohmann | H. Sitter | C. Tudur-Smith | R. Banzi | P. Ravaud | T. Groves | D. Kalra | R. Kush | D. Ghersi | L. Becnel | K. Krleza-Jeric | B. Bierer | C. Gluud | M. Fenner | I. Schlünder | W. Kuchinke | R. Knowles | Gerben Visser | J. Demotes-Mainard | S. Canham | L. Clivio | Jacques Demotes-Mainard | Ghassan Karam | Daniel Shanahan | Barbara Bierer | Serena Battaglia | Christopher Ariyo | Lauren Becnel | Sarion Bowers | Monica Dias | Hélène Faure | Jose Galvez | Pedro Silverio Marques | Jennifer O’Callaghan | Peter van Reusel | Evert-Ben van Veen | Gerben Rienk Visser | Julia Wilson | S. Battaglia | Dylan Spalding | C. Kubiak | M. Matei | Sarion R. Bowers | C. Druml | E. Van Veen | Paul Houston | Christopher Ariyo | M. Dias | H. Faure | Jose Galvez | Ghassan Karam | A. Lukkarinen | Andrew Newbigging | Jennifer O'Callaghan | Daniel R. Shanahan | Peter van Reusel | Julia Wilson | Irene Schlünder
[1] J. Reichman. Rethinking the Role of Clinical Trial Data in International Intellectual Property Law: The Case for a Public Goods Approach , 2009, Marquette intellectual property law review.
[2] Khaled El Emam,et al. Guide to the De-Identification of Personal Health Information , 2013 .
[3] Mark Barnes,et al. A Global, Neutral Platform for Sharing Trial Data. , 2016, The New England journal of medicine.
[4] Anna-Sara Lind. General Data Protection Regulation – final result , 2016 .
[5] D. Altman,et al. The COMET (Core Outcome Measures in Effectiveness Trials) Initiative , 2011, Trials.
[6] Mike Clarke,et al. Good practice principles for sharing individual participant data from publicly funded clinical trials , 2015, Trials.
[7] A. Bailey. The use of nominal group technique to determine additional support needs for a group of Victorian TAFE managers and senior educators , 2013 .
[8] J. Grefenstette,et al. A systematic review of barriers to data sharing in public health , 2014, BMC Public Health.
[9] Robert Cook-Deegan,et al. Broad Consent for Research With Biological Samples: Workshop Conclusions , 2015, The American journal of bioethics : AJOB.
[10] Khaled El Emam,et al. A critical appraisal of the Article 29 Working Party Opinion 05/2014 on data anonymization techniques , 2015 .
[11] PhUSE De-Identification Working Group: Providing De-Identification Standards to CDISC Data Models , 2015 .
[12] P. Várnai,et al. Assessing the research potential of access to clinical trial data , 2015 .
[13] Daniel L. Shaw,et al. US Federal Government Efforts to Improve Clinical Trial Transparency with Expanded Trial Registries and Open Data Sharing. , 2015, AMA journal of ethics.
[14] Heather A. Piwowar,et al. Sharing Detailed Research Data Is Associated with Increased Citation Rate , 2007, PloS one.
[15] Eric G. Campbell,et al. The Changing Nature of Scientific Sharing and Withholding in Academic Life Sciences Research: Trends From National Surveys in 2000 and 2013 , 2016, Academic medicine : journal of the Association of American Medical Colleges.
[16] Harlan M Krumholz,et al. Why data sharing should be the expected norm , 2015, BMJ : British Medical Journal.
[17] Mercè Crosas,et al. Data Authorship as an Incentive to Data Sharing. , 2017, The New England journal of medicine.
[18] Elisabeth Lex,et al. Next-generation altmetrics: responsible metrics and evaluation for open science , 2016 .
[19] A. Marson,et al. Resource implications of preparing individual participant data from a clinical trial to share with external researchers , 2017, Trials.
[20] Nancy S. Burns,et al. Learning What We Didn't Know - The SPRINT Data Analysis Challenge. , 2017, The New England journal of medicine.
[21] R. Banzi,et al. IMPACT Observatory: tracking the evolution of clinical trial data sharing and research integrity , 2016, Biochemia medica.
[22] B. Fitzgerald. Guidance Regarding Methods for De-identification of Protected Health Information in Accordance with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule , 2015 .
[23] Fiona Godlee,et al. [Data sharing statements for clinical trials: a requirement of the International Committee of Medical Journal Editors]. , 2017, Ugeskrift for laeger.
[24] Philippe Ravaud,et al. Differential Globalization of Industry- and Non-Industry–Sponsored Clinical Trials , 2015, PloS one.
[25] T. Lemmens. Pharmaceutical Knowledge Governance: A Human Rights Perspective , 2013, Journal of Law, Medicine & Ethics.
[26] Rorie Edmunds,et al. The ICSU World Data System: Trusted Data Services for Global Science , 2014 .
[27] Douglas J. Joubert,et al. Biomedical Data Sharing and Reuse: Attitudes and Practices of Clinical and Scientific Research Staff , 2015, PloS one.
[28] Christian Ohmann,et al. A metadata schema for data objects in clinical research , 2016, Trials.
[29] Heidi Ledford. Open-data contest unearths scientific gems — and controversy , 2017, Nature.
[30] N. Blomberg,et al. Principles of data management and sharing at European Research Infrastructures , 2014 .
[31] Francis S. Collins,et al. The 21st Century Cures Act - A View from the NIH. , 2017, The New England journal of medicine.
[32] T. Lemmens,et al. Access to Information and the Right to Health: The Human Rights Case for Clinical Trials Transparency , 2011, American Journal of Law & Medicine.
[33] Carly Strasser,et al. Data publication consensus and controversies , 2014, F1000Research.
[34] H. Bauchner,et al. Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors , 2016, Canadian Medical Association Journal.
[35] C. Haug,et al. Whose Data Are They Anyway? Can a Patient Perspective Advance the Data-Sharing Debate? , 2017, The New England journal of medicine.
[36] Z. Alfirevic,et al. Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial , 2010, The Lancet.
[37] M. Sydes,et al. How should individual participant data (IPD) from publicly funded clinical trials be shared? , 2015, BMC Medicine.
[38] B. Knoppers,et al. Can research ethics committees enable clinical trial data sharing , 2017 .
[39] Markus Schweizer,et al. Group Techniques For Program Planning A Guide To Nominal Group And Delphi Processes , 2016 .
[40] A. Vickers. Sharing raw data from clinical trials: what progress since we first asked “Whose data set is it anyway?” , 2016, Trials.
[41] Ben Goldacre,et al. OpenTrials: towards a collaborative open database of all available information on all clinical trials , 2016, Trials.
[42] C. Gross,et al. Predictors of clinical trial data sharing: exploratory analysis of a cross-sectional survey , 2014, Trials.
[43] Yvonne M. Socha,et al. OUT OF CITE, OUT OF MIND: THE CURRENT STATE OF PRACTICE, POLICY, AND TECHNOLOGY FOR THE CITATION OF DATA CODATA-ICSTI Task Group on Data Citation Standards and Practices , 2013 .